We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

186 hedge funds and large institutions have $458M invested in Regenxbio in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 50

20% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 25

3% more funds holding

Funds holding: 181 → 186 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.46% less ownership

Funds ownership: 88.82% → 88.36% (-0.46%)

10% less capital invested

Capital invested by funds: $512M → $458M (-$53.7M)

77% less call options, than puts

Call options by funds: $1.5M | Put options by funds: $6.66M

Holders
186
Holders Change
+5
Holders Change %
+2.76%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
66
Reduced
50
Closed
25
Calls
$1.5M
Puts
$6.66M
Net Calls
-$5.16M
Net Calls Change
-$4.96M

Top Buyers

1
ACM
ADAR1 Capital Management
Texas
+$6.9M
2
IHAM
Integral Health Asset Management
New York
+$3.96M
3
RG
Redmile Group
California
+$3.94M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.82M
5
Bank of America
Bank of America
North Carolina
+$3.04M

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$9.08M
2
JP Morgan Chase
JP Morgan Chase
New York
-$6.52M
3
MB
MPM BioImpact
Massachusetts
-$6.18M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$3.13M
5
AG
Artal Group
Luxembourg
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$92.8M +$2.87M +235,128 +3%
RG
2
Redmile Group
California
$51.3M +$3.94M +323,100 +7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$45.8M -$9.08M -744,791 -15%
State Street
4
State Street
Massachusetts
$29.2M -$1.1M -90,352 -3%
JP Morgan Chase
5
JP Morgan Chase
New York
$26M -$6.52M -535,165 -18%
Morgan Stanley
6
Morgan Stanley
New York
$14.2M +$2.07M +170,024 +14%
IHAM
7
Integral Health Asset Management
New York
$13.4M +$3.96M +325,000 +34%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$12.1M +$521K +42,735 +4%
APM
9
Avidity Partners Management
Texas
$11.9M -$2.04M -167,500 -13%
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$11.7M +$3.82M +313,394 +39%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$11.4M +$537K +44,037 +4%
ACM
12
Aquilo Capital Management
California
$9.76M +$298K +24,460 +3%
Goldman Sachs
13
Goldman Sachs
New York
$7.8M +$1.15M +94,144 +15%
ACM
14
ADAR1 Capital Management
Texas
$5.97M +$6.9M +566,308 +20,974%
Assenagon Asset Management
15
Assenagon Asset Management
Luxembourg
$5.87M -$3.13M -256,512 -31%
Northern Trust
16
Northern Trust
Illinois
$5.12M +$679K +55,737 +13%
Bank of America
17
Bank of America
North Carolina
$4.68M +$3.04M +249,697 +127%
Charles Schwab
18
Charles Schwab
California
$4.38M +$452K +37,055 +10%
SGL
19
Sonic GP LLC
Hawaii
$4.23M -$610K -50,000 -11%
RI
20
RTW Investments
New York
$3.67M – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$3.36M -$233K -19,125 -6%
WM
22
WS Management
Florida
$3.15M -$964K -79,059 -21%
SL
23
Siren LLC
Connecticut
$2.98M +$3.46M +284,000 New
Ameriprise
24
Ameriprise
Minnesota
$2.85M -$38.6K -3,164 -1%
GTC
25
Ghost Tree Capital
New York
$2.78M +$1.16M +95,000 +56%
1
2 3 4 5

RGNX Hedge Fund Activity: Q3 2024 in Review

186 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2024, worth a combined $458M — down 10% from $512M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new RGNX positions and 25 closed out — a net gain of 5 holders — while 66 added to existing stakes and 50 trimmed.

The largest buyer was ADAR1 Capital Management, adding an estimated $6.9M. The largest seller was Vanguard Group, cutting an estimated $9.08M.

  • 186 institutional investors held Regenxbio (RGNX) as of Q3 2024, up from 181 in Q2 2024.
  • Funds reported $458M of Regenxbio stock for Q3 2024, down 10% quarter-over-quarter.
  • 30 funds opened new Regenxbio positions in Q3 2024 and 25 closed out, a net change of +5 holders.
  • The largest Regenxbio buyer in Q3 2024 was ADAR1 Capital Management, an estimated $6.9M added.
  • The largest Regenxbio seller in Q3 2024 was Vanguard Group, an estimated $9.08M sold.

Based on aggregated 13F filings for Q3 2024.